PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway[S]

PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway[S]

Platelet-activating factor (PAF), 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, is a potent phospholipid mediator and has been reported to be localized in atherosclerotic plaque. However, its role in the progression of atherosclerosis remains unclear. In the present study, we investigated the role...

Full description

Bibliographic Details
Main Authors:	Yun H. Kim, Seung J. Lee, Kyo W. Seo, Jin U. Bae, So Y. Park, Eun K. Kim, Sun S. Bae, Jae H. Kim, Chi D. Kim
Format:	Article
Language:	English
Published:	Elsevier 2013-10-01
Series:	Journal of Lipid Research
Subjects:	platelet-activating factor platelet-activating factor receptor β-arrestin2 extracellular signal-regulated kinase matrix metalloproteinase-2
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520352949

Similar Items

Pharmacological characterization of prehispanolone, a PAF receptor antagonist.
Published: (1991)

The emerging roles of PAF acetylhydrolase
by: Thomas M. McIntyre, et al.
Published: (2009-01-01)

Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer
by: Juliana L. Souza, et al.
Published: (2020-12-01)

Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesiss⃞
by: Jiawei Chen, et al.
Published: (2007-11-01)

Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis
by: Stefan Blankenberg, et al.
Published: (2003-07-01)

Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins
by: Vasilis Tsimihodimos, et al.
Published: (2003-05-01)

The Clinical Significance of β-arrestin 2 Expression in the Serum of  Non-small Cell Lung Cancer Patients
by: Zhengqing WU, et al.
Published: (2011-06-01)

Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress
by: Maria Luisa Balestrieri, et al.
Published: (2003-02-01)

The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity
by: Anna I. Kakafika, et al.
Published: (2003-10-01)

Selective inhibitors of a PAF biosynthetic enzyme lysophosphatidylcholine acyltransferase 2[S]
by: Megumi Tarui, et al.
Published: (2014-07-01)

New Insights into Arrestin Recruitment to GPCRs
by: Martin Spillmann, et al.
Published: (2020-07-01)

Interaction of Protease-Activated Receptor 2 with G Proteins and Beta-Arrestin 1 Studied by Bioluminescence Resonance Energy Transfer
by: Mohammed Akli eAyoub, et al.
Published: (2013-12-01)

Consumption of Enriched Yogurt with PAF Inhibitors from Olive Pomace Affects the Major Enzymes of PAF Metabolism: A Randomized, Double Blind, Three Arm Trial
by: Maria Detopoulou, et al.
Published: (2021-05-01)

Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth
by: Valerie A. Cruz Flores, et al.
Published: (2021-09-01)

Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism
by: Nasopoulou Constantina, et al.
Published: (2011-11-01)

Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase
by: Hugo C Castro Faria Neto, et al.
Published: (2005-03-01)

Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study
by: Bastsetseg Ulambayar, et al.
Published: (2019-07-01)

Methylglyoxal, Glycated Albumin, PAF, and TNF-α: Possible Inflammatory and Metabolic Biomarkers for Management of Gestational Diabetes
by: Gabriele Piuri, et al.
Published: (2020-02-01)

Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism
by: Paraskevi Detopoulou, et al.
Published: (2021-01-01)

PAF-AH catalytic subunits modulate the Wnt pathway in developing GABAergic neurons
by: Idit Livnat, et al.
Published: (2010-05-01)

Shp2 régule la phosphorylation des tyrosines de l'arrestine
by: Germain, Pascale
Published: (2009)

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
by: Eileen Deuster, et al.
Published: (2021-09-01)

Platelet Functions during Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation
by: Alexandre Mansour, et al.
Published: (2020-07-01)

Design, Synthesis and Anti-Platelet Aggregation Activity Study of Ginkgolide-1,2,3-triazole Derivatives
by: Jian Cui, et al.
Published: (2019-06-01)

No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
by: Yves Denizot, et al.
Published: (2003-01-01)

Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications
by: Rosa M. Muñoz-Cano, et al.
Published: (2019-08-01)

Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus
by: Takeshi Kujiraoka, et al.
Published: (2003-10-01)

To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase
by: Gopal Kedihitlu Marathe, et al.
Published: (2014-09-01)

SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism
by: Shu Shen, et al.
Published: (2021-04-01)

Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis
by: Miguel L. Rufail, et al.
Published: (2005-12-01)

Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets
by: Gizem Kayki-Mutlu, et al.
Published: (2021-01-01)

Effect of safflower yellow on platelet activating factor mediated platelet activation in patients with coronary heart disease
by: Damin Huang, et al.
Published: (2012-07-01)

Targeting Neurodegeneration in Alzheimer’s Disease Using Natural Products Derived from Maya Traditional Medicine
by: Taylor, Matthew W
Published: (2014)

Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
by: Ayla Eser, et al.
Published: (2016-02-01)

Antiplatelet Aggregation and Platelet Activating Factor (PAF) Receptor Antagonistic Activities of the Essential Oils of Five Goniothalamus Species
by: Juriyati Jalil, et al.
Published: (2010-07-01)

AMPK-Mediated Regulation of Alpha-Arrestins and Protein Trafficking
by: Allyson F. O’Donnell, et al.
Published: (2019-01-01)

Improvement of Morphine-Mediated Analgesia by Inhibition of β-Arrestin 2 Expression in Mice Periaqueductal Gray Matter
by: Yuting Li, et al.
Published: (2009-03-01)

Effect of adjuvant nicorandil therapy on inflammation, plaque stability and platelet function in patients with unstable angina
by: Liang Lu, et al.
Published: (2017-02-01)

Phosphorylation of β-arrestin2 at Thr383 by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs
by: Elisabeth Cassier, et al.
Published: (2017-02-01)

β-Arrestin 2 and ERK1/2 Are Important Mediators Engaged in Close Cooperation between TRPV1 and µ-Opioid Receptors in the Plasma Membrane
by: Barbora Melkes, et al.
Published: (2020-06-01)